Answers are grounded in this paper and cite their sources.
The number of Genome Wide Association Studies (GWAS) of schizophrenia, as well as that of subjects studied have increased dramatically over the last years.Nevertheless, biologically meaningful interpretation of GWAS results remains very difficult due to the complexity and heterogeneity of both clinical and genetic aspects of schizophrenia, and the small contribution of each single gene to the disease.Our study presented a methodology that integrated GWAS results with gene expression data, and applied it to schizophrenia.Integration of two types of information, of both DNA-level and of messenger RNA (mRNA) level, increases the validity and reliability of the results and improves our understanding of the biological meaning of the GWAS results.We comment here on the methodology used and the main result of our study.
No takes yet. Share an insight, caveat, or question.
Libi Hertzberg (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: